Treatment of aggressive prostate cancer with triptorelin in real life in France: the TALISMAN study. Lebret T, Crehange G, Pello-Leprince-Ringuet N, Perrot V, et al. Ther Adv Urol 2025;17:17562872251382970.

Read + Share

Amedeo Smart

Independent Medical Education

Lebret T, Crehange G, Pello-Leprince-Ringuet N, Perrot V, et al. Treatment of aggressive prostate cancer with triptorelin in real life in France: the TALISMAN study. Ther Adv Urol 2025;17:17562872251382970.
PMID: 41122488